|Bid||46.04 x 1000|
|Ask||46.08 x 800|
|Day's Range||45.14 - 46.17|
|52 Week Range||40.56 - 63.04|
|PE Ratio (TTM)||13.01|
|Earnings Date||Jul 26, 2018 - Jul 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||52.42|
Southeast Anesthesiology Consultants will have to make tough decisions regarding its physicians if the court doesn't intervene on its behalf.
A judge is expected to weight in on the ongoing contract dispute between Atrium Health and Southeast Anesthesiology Consultants.
MEDNAX, Inc. (MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is pleased to announce that it has partnered with Pacira Pharmaceuticals, Inc. (PCRX) to address the ongoing use of opioids during and after cesarean surgery by launching a national collaborative aimed at addressing the Quadruple Aim through the implementation of an Enhanced Recovery after Cesarean Surgery (ERACS™) program. The collaborative will be multi-disciplinary in nature, engaging the expertise of maternal-fetal medicine physicians, anesthesiologists, obstetricians and perioperative nurses to improve the patient experience as well as maternal and infant health, reduce the total cost of care and enhance provider satisfaction.
MedData, Inc., a MEDNAX (MD) company and a leading provider of patient-facing financial services for hospitals and health systems, today announced Emily Fisher as Acting President. Fisher has worked at MedData for over 16 years, progressing from Patient Advocate to Chief Operating Officer, where she has served since fall of 2016. “I am grateful for this opportunity and eager to lead a truly innovative company that is helping define the future of the entire revenue cycle management industry. It is my privilege to work with such a dedicated team of employees, and together we will continue to honor the great responsibility our clients have given us by treating their patients with the tremendous care they deserve,” Fisher said.
MEDNAX, Inc. , today announced that it is scheduled to make a presentation on Friday, June 8, 2018 at 1:00 p.m. ET to investors attending the Jefferies 2018 Global Healthcare Conference in New York.
A judge did not grant Southeast Anesthesiology Consultants request for immediate relief in the form of a temporary restraining order this week.
Stock Research Monitor: ACHC, MD, and TVTY LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want a free Stock Review on DVA sign up now at www.wallstequities.com/registration . Research reports have been ...
Southeast Anesthesiology Consultants has asked the court to intervene in its ongoing contract dispute with Atrium Health.
MEDNAX, Inc. , today announced that it is scheduled to make a presentation on Thursday, May 17, 2018 at 8:00 a.m. PT to investors attending the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas.
Southeast Anesthesiology Consultants (“Southeast”), an affiliate of MEDNAX, Inc. (MD) today filed a motion with the North Carolina Business Court seeking a temporary restraining order and preliminary injunction against Atrium Health and Dr. Thomas Wherry’s Scope Anesthesia. The motion seeking a temporary restraining order is necessary given that for some time, Dr. Wherry and Atrium have been attempting to recruit physicians from Southeast, in violation of the contract Southeast has with Atrium as well as contrary to statements both Atrium and Dr. Wherry have made to the press.
NEW YORK, May 10, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Energy ...
Undervalued companies, such as Foot Locker and Biostar Pharmaceuticals, are those that trade at a price below their actual values. Investors can benefit from buying these companies while they areRead More...
CHARLOTTE, N.C., May 7, 2018 /PRNewswire/ -- Atrium Health has filed an Amended Answer and Counterclaims against Mednax (MD), the Florida-based corporation that bought the physician-owned Southeast Anesthesiology Consultants practice for $200 million in 2010. Atrium Health has filed its amended counterclaims because Mednax has increased the intensity of its false and misleading fear-based ad campaign, and at the same time information has been revealed about Mednax's apparent corporate difficulties. Atrium Health has made clear that it will not enter into a new agreement with Mednax.
The Sunrise, Florida-based company said it had profit of 68 cents per share. Earnings, adjusted for amortization costs and stock option expense, came to 89 cents per share. The results topped Wall Street ...
MEDNAX, Inc. , the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.68 per diluted share for the three months ended March 31, 2018.
Short-seller Jim Chanos bets against two health-care companies: They 'might be worth nothing'|| 105161423
Atrium Health's CEO addressed an ongoing legal battle tied to its anesthesia services on Wednesday.
MEDNAX, Inc. (MD), today announced the acquisition of Women’s Radiology Associates, LLP, a private radiology physician group based in Houston. The practice will integrate with Synergy Radiology Associates, a MEDNAX-affiliated physician practice, also based in Houston. This marks the Company’s sixth radiology services practice acquisition, further establishing MEDNAX as the partner of choice for leading radiology practices and physician services by combining physician excellence with world-class technological capabilities.
MEDNAX, Inc. , will host an investor conference call and webcast on Monday, May 7, 2018 at 11:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2018.
This week's Top 25 List ranks Charlotte-area physician groups by number of physicians.
On a positive note, the broader healthcare looks delighted with the massive tax cuts. Also, the scenario within the Medical Device space seems equally bright.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting MD. Over the last one-month, outflows of investor capital in ETFs holding MD totaled $1.39 billion.
MedData, Inc., a MEDNAX company and a leading provider of patient-facing financial services for hospitals and health systems, today announced the debut of its comprehensive patient financial platform, MedData OneTouch.